Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · May 15, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Lung cancer is currently the leading cause of death from malignant tumors worldwide. Surgery is the primary treatment method for lung cancer, and breakthroughs in thoracic surgical techniques play a crucial role in the diagnosis and treatment of lung cancer. Medical ultrasound technology, due to its non-invasive, flexible, convenient, and economical characteristics, is widely used in clinical practice. With the advancement of ultrasound technology and the need to address clinical challenges, ultrasound imaging technology has seen new developments in the field of thoracoscopic surgery.
In t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who plan to accept VATS surgery.
- Exclusion Criteria:
- • 1. Patients who can not obtain detailed clinical information;
- • 2. Patients or their family members who can not understand the conditions and objectives of the study or refuse to participate in the study;
- • 3. Patients with conditions affecting observation, such as skin lesions, infections, or scars in the area of the chest wall to be examined.
Trial Officials
Shanqing Li, PhD, and MD
Study Director
Peking Union Medical College Hospital
Qingli Zhu, PhD, and MD
Principal Investigator
Peking Union Medical College Hospital
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0